By Adriano Marchese
WELL Health Technologies said its subsidiary has received 62 million Canadian dollars ($44.3 million) in a series B investment funding round ahead of a planned public listing.
The Canadian digital healthcare company said Friday that its majority-owned subsidiary Wellstar Technologies has entered into agreements for share investments at an offering price of C$1.50 apiece.
WELL said that the series B financing--a type of fundraising used for early-stage companies--is supported by three of Canadian fund investors, Mawer Investment Management, Edgepoint Wealth Management and Picton Investments.
The company plans to use the funds towards future acquisitions, artificial intelligence-related offerings, organic growth initiatives and general corporate purposes.
The financing is expected to close early in December, and Wellstar is targeting a public listing sometime in 2026.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
October 31, 2025 08:52 ET (12:52 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.